Low-Level Laser Therapy and Injectable Platelet-Rich Fibrin for Thin Gingival Phenotype.

Faculty of Dental Medicine for Girls

Status and phase: Completed; Phase 3

Conditions: Periodontal Diseases

Treatments: Other: injecable platelet rich fibrin, and low level laser therapy radiation.; Biological: Biologic Agent: injectable platelet rich fibrin.

Study type: Interventional

Funder types: Other

Identifiers

NCT06756854

P-ME-23-05

Details and patient eligibility

About

Management of thin gingival phenotype using non-surgical methods (injection of liquid platelet rich fibrin and exposure to low level laser therapy

Full description

Thin gingival phenotype can lead to recession and root exposure. Liquid prf can be obtained by centrifugion of blood sample on speed 700 rpm for 3 min, then injection of this liquid in the attached gingiva and muco-gingival junction (3 times with 7 days interval) for the first group. The second group will be injected with I-PRF in the same method in addition to exposure to Low Level Laser therapy (after each injection of I-PRF). This method is expected to increase the thickness of the gingiva.

Enrollment: 7 patients

Sex: All

Ages: 18 to 40 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• free systimatically good oral hygiene gingival thickness less than 1mm

Exclusion criteria

• pregnancy or lactation pereiodontitis periodontal surgery orthodontic ttt tooth mobility,bruxism,crowding,missing or supernumerary teeth smoking

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

7 participants in 2 patient groups

Test group: injectable platelet rich fibrin+ low level laser therapy

Active Comparator group

Description:

patients with thin gingival phenotype (gingival thickness less than 1mm) recieve I-PRF+LLLT radiation just after the injection for 3 sessions with 7 days interval between the sessions.

Treatment:

Other: injecable platelet rich fibrin, and low level laser therapy radiation.

Control group :I-PRF group

Active Comparator group

Description:

patients with thin gingival phenotype received I-PRF alone in 3 sessions, with 7 days interval between the sessions.

Treatment:

Biological: Biologic Agent: injectable platelet rich fibrin.